STE Stock Recent News
STE LATEST HEADLINES
STERIS' (STE) fiscal 2024 second-quarter results reflect continued momentum in the Healthcare business.
Beyond analysts' top -and-bottom-line estimates for Steris (STE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2023.
DUBLIN, IRELAND, Oct. 24, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 second quarter financial results at 9:00 a.m. ET on November 8, 2023. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.
On the capital equipment side for STERIS (STE), the easing of supply-chain issues and reduced lead times are boosting shipments.
STERIS' (STE) healthcare segment benefits from procedure recovery, boosting investors' optimism.
DUBLIN, IRELAND , Aug. 30, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Morgan Stanley Healthcare Conference in New York City on Wednesday, September 13, 2023. Dan Carestio, President and CEO of STERIS will present at 8:10 a.m. Eastern Time.
Investors are optimistic about STERIS' (STE) successful integration of the recently-acquired business and raised guidance.
Barring Life Sciences and Dental, rest of STERIS (STE) operating segments report organic revenue growth in fiscal Q1.
Steris (STE) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $1.90 per share a year ago.
Medical equipment provider Steris on Tuesday raised its profit forecast for fiscal 2024 after strength in its core healthcare business boosted first-quarter results above Wall Street estimates.